NEW YORK, NY / ACCESS Newswire / April 9, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a ...

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Viatris Inc. (NASDAQ:VTRS) between August 8, 2024 and ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN VIATRIS INC. (VTRS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of ...

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) securities between ...

defendants failed to disclose the truth about the failed inspection of Viatris' Indore, India facility, which resulted in the FDA issuing a warning letter and import alert. Specifically ...

NEW YORK - March 31, 2025 ( NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS).

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Viatris Inc. (“Viatris” or the “Company”) ( ...

Viatris also provided an update on remediation work at a manufacturing facility in India following receipt of a warning letter and import alert from the U.S. Food and Drug Administration ...

The investigation focuses on the propriety of Viatris' disclosures to its investors about the FDA's inspections of the company's manufacturing facility in Indore, India.

On December 23, 2024, Viatris disclosed that “following an inspection by the U.S. FDA” at the Company’s manufacturing facility in Indore “the Agency has issued a Warning Letter ...